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Abstract
Gene 9 minor coat protein from bacteriophage M13 is known to be located in the inner membrane after phage infection of
Escherichia coli. The way of insertion of this small protein (32 amino acids) into membranes is still unknown. Here we show
that the protein is able to insert in monolayers. The limiting surface pressure of 35 mN/m for 1,2-dioleoyl-sn-glycero-3-
phosphocholine and 1,2-dioleoyl-sn-glycero-3-phosphoglycerol lipid systems indicates that this spontaneous insertion can
also occur in vivo. By carboxyfluorescein leakage experiments of vesicles it is demonstrated that protein monomers, or at
least small aggregates, are more effective in releasing carboxyfluorescein than highly aggregated protein. The final
orientation of the protein in the bilayer after insertion was addressed by proteinase K digestion, thereby making use of the
unique C-terminal location of the antigenic binding site. After insertion the C-terminus is still available for the enzymatic
digestion, while the N-terminus is not. This leads to the overall conclusion that the protein is able to insert spontaneously into
membranes without the need of any machinery or transmembrane gradient, with the positively charged C-terminus
remaining on the outside. The orientation after insertion of gene 9 protein is in agreement with the ‘positive inside
rule’. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cleavable leader peptides or uncleaved signals can
function to initiate translocation of proteins across
membranes [1]. However, translocation of short do-
mains with no or a small number of charged residues
often does not require such signals. Examples of
short proteins that translocate in this way include
the Pf3 and M13 major coat proteins [2]. Whether
gene 9 minor coat protein (g9p) of bacteriophage
M13 is also able to translocate across membranes
will be addressed in this paper.
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Abbreviations: g7p, g8p, g9p, respectively gene 7, gene 8 and
gene 9 protein; C16S, g9p with mutation Cys16 to Ser; C16S/
S32C, g9p with mutations Cys16 to Ser and Ser32 to Cys; CF,
5,6-carboxy£uorescein; DOPC, 1,2-dioleoyl-sn-glycero-3-phos-
phocholine; DOPG, 1,2-dioleoyl-sn-glycero-3-phosphoglycerol ;
L/P, lipid to protein molar ratio; LUV, large unilamellar vesicle ;
PMSF, phenylmethylsulphonyl £uoride; SDS, sodium dodecyl
sulphate; TFA, tri£uoroacetic acid; TFE, tri£uoroethanol
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g9p is a minor coat protein of bacteriophage M13.
The amino acid sequence of this 32-residue protein




A few copies of the g9p are located together with
g7ps at one end of this 880 nm long cylindrically
shaped ¢lamentous phage [4]. The main constituents
of the bacteriophage are the single stranded DNA,
surrounded all along the cylinder with approx. 2700
copies of g8ps, also known as major coat proteins.
Five copies each of the minor coat proteins, which
are the products of gene 3 and gene 6, cover the
other end.
Bacteriophage M13 uses Escherichia coli cells as a
host, entering by the F-pilus. Coat proteins, as well
as non-structural viral proteins, such as gene 1, gene
4, gene 11 proteins, and host proteins (thioredoxin)
play a role in the assembly process of newly formed
bacteriophages (for reviews see [5^9]). The gene 9
and gene 7 minor coat proteins were shown to inter-
act with a hairpin loop in the viral DNA [10], there-
by playing an important role in initiating the assem-
bly process. Because of this interaction with the
packaging signal the phage end containing g9ps
and g7ps is the ¢rst to emerge from the cell [11].
Prior to incorporation in the bacteriophage g9p is
known to be located in the E. coli inner membrane
[12], probably mainly K-helical, as has been demon-
strated in model membranes [13].
The protein is synthesised and inserted into the
inner membrane [12] without any signal sequence.
The ¢nding that the N-terminus of the g9p contains
a formyl group, and therefore is not processed [14],
gives rise to the idea that the protein must insert
rapidly into the membrane, before proteolytic pro-
cessing can occur. g9p does not contain a cleavable
signal peptide. However, when looking at the se-
quence there are similarities with the general features
of signal peptides, although the sequence is in a re-
versed order (positive charges are located C-termi-
nally from the hydrophobic region). Similar to signal
peptides [15,16], g9p contains a hydrophobic stretch
followed by a hydrophilic basic region with two ar-
ginine residues. The structure of signal peptides
seems to be designed for interaction with lipids, as
demonstrated from studies of the interaction with
and translocation into phospholipid vesicles [17^19].
The N-terminal side of g9p is the most likely side to
insert, since the N-terminus remains formylated after
membrane insertion and is still formylated after as-
sembly in the viral particle [14].
In the present paper we contribute to the model
presented above showing the penetrative strength of
g9p by monolayer and vesicle leakage experiments.
The orientation of g9p, after reconstitution and in-
sertion, is addressed by proteinase K digestion, there-
by making use of the C-terminal location of the anti-
genic site.
2. Materials and methods
2.1. Materials
Tri£uoroacetic acid (TFA) was obtained from
Merck (Darmstadt, Germany), and tri£uoroeth-
anol (TFE) was obtained from Acros (Pittsburgh,
PA, USA). 1,2-Dioleoyl-sn-glycero-3-phosphoglycer-
ol (DOPG) and 1,2-dioleoyl-sn-glycero-3-phospho-
choline (DOPC) were obtained from Avanti Polar
Lipids (Alabaster, AL, USA). Proteinase K was
from Boehringer (Mannheim, Germany). Alkaline
phosphatase was from Boehringer. Polycarbonate ¢l-
ters (200 nm) were from Avestin (Ottawa, Canada).
The mini-extruder device was from Milsch Equip-
ment (Laudenbach, Germany). 5,6-Carboxy£uores-
cein (CF) was obtained from Kodak, and used after
puri¢cation. The M13mp18rf template was from
Pharmacia (Uppsala, Sweden). The Quikchange pro-
tocol was from Stratagene (La Jolla, CA, USA). The
g9p was prepared by solid phase synthetic techniques
and characterised as described before [13]. The N-
terminus was synthesised with a formyl group.
2.2. Solubilisation of G9p in TFE
The protein was ¢rst dissolved in a small volume
of TFA (10^20 Wl/mg of protein) and dried under a
stream of nitrogen. Next, the protein was washed
two times with TFE, followed by evaporation of
the TFE under a stream of nitrogen, to remove re-
sidual TFA. Finally the protein was dissolved in a
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known volume of TFE. The protein concentration
was determined by the procedure of Peterson [20]
with bovine serum albumin as a standard.
2.3. Monolayer experiments
For the monolayer experiments, the pressure was
measured by the Wilhelmy balance method using ¢l-
ter paper in a thermostatically controlled box, using
a Cahn D202 microbalance [21]. This method is
based on the determination of the weight of the ¢lter
paper, which is partially submersed in the aqueous
subphase. Di¡erences in plate weight are directly re-
lated to surface pressure. The measurements were
performed as follows. The lipid monolayers were
spread from a chloroform solution to give an initial
surface pressure between 15 and 40 mN/m on a sub-
phase solution of 10 mM Tris-HCl, 0.2 mM EDTA,
pH 8.0 (TE8). During the measurements the temper-
ature was kept at 22.5 þ 1‡C, and the subphase was
continuously stirred with a magnetic bar. Instead of
a te£on dish a glass dish with a te£on coated rim was
used, which allows more rigorous cleaning of the
dish between the separate experiments. The glass
dish had a volume of 4 ml and a surface of 4.41
cm2. Protein, dissolved in 30 Wl of TFE/TE8 (1:1)
was added through a hole on one side of the dish.
Unless stated otherwise, a saturating amount of pro-
tein was injected into the subphase. The pressure
changes were followed until the surface pressure in-
crease had reached a maximal value, usually within
30 min.
2.4. Reconstitution of g9p into lipid vesicles
To reconstitute the protein into lipid bilayers, de-
sired amounts of lipids (in chloroform) and protein
(in TFE) were mixed, dried under a stream of nitro-
gen and lyophilised overnight to remove residual sol-
vent. The sample was rehydrated in the desired vol-
ume of bu¡er and freeze-thawed several times. To
prepare large unilamellar vesicles (LUVs) the sample
was extruded 31 times through a polycarbonate ¢lter
with 200 nm pores. The ¢lters were mounted in a
mini-extruder device as described in the literature
[22]. Vesicles without protein were prepared in the
same way.
2.5. Sucrose gradient centrifugation
Samples were brought on top of a linear 5^40%
(w/w) sucrose gradient in 10 mM Tris, 0.2 mM
EDTA, 150 mM NaCl, pH 8.0, and centrifuged for
18 h at 110 000Ug at 4‡C in a Beckman SW41 rotor.
To enable visualisation of the lipid-protein com-
plexes, the gradient was fractionated and analysed
by gel electrophoresis and Western blotting as de-
scribed below.
2.6. Preparation of carboxy£uorescein loaded vesicles
and determination of release of
carboxy£uorescein
An amount of 12.5 Wmol of lipid (DOPC or
DOPG), dissolved in chloroform, was dried under
a stream of nitrogen followed by high vacuum for
several hours. CF (121 mM) in 2 ml of a solution of
10 mM Tris-HCl, 0.2 mM EDTA, pH 8.0 was used
to rehydrate the lipids. The solution was vortexed
and subjected to several cycles of freezing in liquid
nitrogen and thawing in hot water to form multila-
mellar liposomes. Subsequently, the vesicles were
converted into LUVs by extrusion as described
above. External CF was removed by passing the
vesicles over a P10 column (1.5U20 cm), pre-equili-
brated with 10 mM Tris-HCl, 0.2 mM EDTA, 50
mM NaCl, pH 8.0. After collection of the CF-loaded
vesicles, they were diluted with the same bu¡er to
give a maximal optical density at 490 nm between
0.09 and 0.1 in a 1 cm cuvette. Protein was added
in a 1:1 mixture of TFE:bu¡er to 1 ml of the vesicle
solution and stirred. The release of CF was followed
in time on a Perkin-Elmer LS-5 £uorescence spec-
trometer (excitation slit 5 nm, emission slit 5 nm)
at an excitation wavelength of 490 nm, and an emis-
sion wavelength of 520 nm. The measurements were
performed at room temperature. Maximal (100%)
£uorescence was obtained by addition of 20 Wl of
10% (v/v) of Triton X-100. To check for background
leakage, an equal volume of solvent without protein
was added. The lipid to protein molar ratios (L/P) of
the samples were calculated from the known amount
of protein added, and the phospholipid concentra-
tion determined by total £uorescence intensity of
CF after addition of cholate (¢nal concentration 50
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mM) to release all CF from the vesicles. An average
diameter of the vesicles of 200 nm is assumed.
2.7. Overexpression and mutagenesis of g9p
Overexpression of g9p was achieved by introduc-
ing M13 gene 9 into the pT7-7 vector [23]. By PCR,
using M13mp18 RF as a template, NdeI and BamHI
sites were introduced respectively preceding and fol-
lowing the gene 9 protein-coding gene. After inser-
tion in the respective sites of pT7-7, the plasmid was
introduced in E. coli BL21(DE3) strain and expres-
sion of g9p was obtained in LB medium after induc-
tion by IPTG to a ¢nal concentration of 0.25 mM.
Cells were harvested 1 h after induction. The pres-
ence of g9p before and after induction was analysed
as described below. Mutant g9ps were produced us-
ing the Quikchange protocol. By sequencing the plas-
mid DNA the presence of the mutation was checked.
2.8. Protein analysis by sodium dodecyl sulphate
(SDS) gel electrophoresis and Western blotting
To verify the presence of the g9p after overexpres-
sion, gel electrophoresis on a tricine SDS polyacryl-
amide gel was performed [24]. Western blotting [25]
and immunodetection were used to verify the reac-
tion with antibody, using goat-anti-rabbit IgG con-
jugated with alkaline phosphatase as the secondary
antibody. Primary antibodies were raised against
synthetic protein in female New Zealand white rab-
bits. Spot intensities were determined by image anal-
ysis after white light scanning of the blot, thereby
using a calibration curve from a series created by
blotting of known relative amounts of protein.
2.9. Cleavage of g9p by proteinase K
Samples of reconstituted g9p in 200 nm lipid
vesicles, as well as the 200 nm lipid vesicles used in
the insertion experiments, were produced as de-
scribed above. For insertion, g9p, dissolved in a
small volume of TFE, was added to the lipid vesicles
and left at room temperature for 1 h. 1 ml of the
mixtures contained 1.6 Wmol lipid and 3.2 nmol g9p,
resulting in an L/P ratio of 500. Vesicles with protein
attached were puri¢ed from non-interacting protein
by sucrose gradient. The clear visible band was iso-
lated and dialysed for 16 h against bu¡er. After dial-
ysis proteinase K was added, at a concentration of 50
Wg/ml, and the samples were incubated at room tem-
perature during 1 h. The reaction was stopped by
adding phenylmethylsulphonyl £uoride (PMSF; ¢nal
concentration 5 mM), an equal volume of gel elec-
trophoresis sample bu¡er (double concentration) and
immediately putting in a boiling water bath for 3 min.
The samples were then further analysed by gel elec-
trophoresis and Western blotting as described above.
3. Results
3.1. Monolayer experiments
The interaction of g9p with lipid monolayers was
monitored by measurement of the surface pressure
increase in a constant area setup. Since extrinsic pro-
teins and other non-penetrative agents do not induce
an increase of the monolayer surface pressure [26],
this e¡ect can be related to the degree and nature of
penetration. The highest initial pressure allowing
penetration, the limiting surface pressure, is often
used as a measure of the penetrative force. The g9p
is surface active itself, spontaneously forming a pro-
tein monolayer to a surface pressure of 23 mN/m
after introduction into the subphase. The injection
Fig. 1. Surface pressure increase after injection of 11.6 nmol
(resulting in a 2.9 WM concentration in the subphase) g9p in
the subphase of monolayers of DOPC (b, dotted line) and
DOPG (a, solid line) as a function of the initial pressure.
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of g9p under a phospholipid monolayer gave rise to
a surface pressure increase, which reached a stable
end level after 20^30 min. Injection of the solvent
alone had a small e¡ect on the surface pressure of
0.5^1.0 mN/m. The maximal pressure increase in
DOPC is dependent on the amount of protein added
in the subphase up to a saturating level. For the
negatively charged DOPG similar results were found
(data not shown). The saturating level was deter-
mined (data not shown) and for further experiments
an injected amount of 11.6 nmol of protein was chos-
en, which is su⁄cient to saturate the monolayer and
produce a stable end pressure within 30 min. Fig. 1
shows the dependence of the ¢nal pressure increase
on the initial pressure with a DOPC monolayer. A
higher initial surface pressure results in a smaller
pressure increase, indicating a more restricted pene-
tration. From this ¢gure, a limiting surface pressure
of about 35 mN/m could be derived. Measurements
performed with DOPG monolayers, also shown in
Fig. 1, resulted in the same limiting surface pressure
of about 35 mN/m, although the slope of the curve
was steeper.
3.2. Leakage of carboxy£uorescein
In addition to the insertion of g9p into phospho-
lipid monolayers the e¡ect of the g9p on bilayers was
investigated. Fig. 2 shows the in£uence of the TFE/
g9p ratio on the rate of leakage of CF-loaded 200
nm DOPC vesicles. The initial leakage rate is higher
at a higher TFE/g9p ratio. No leakage was observed
upon addition of TFE alone. Decreasing the percent-
age TFE (v/v) in the protein solution, before adding,
also decreases the leakage rate as shown in Fig. 2
(inset).
3.3. Location of the antigenic site
The antigenic site of the g9p was predicted to be
located at the C-terminal side (Fig. 3A). We found
evidence for this, based on the expression and detec-
tion of two mutant proteins. In both mutant proteins
the Cys16 was changed to Ser. Additionally, one mu-
tant protein also contained the Ser32 to Cys mutation
(C16S/S32C). Although both mutant proteins were
present after overexpression, as shown for the
C16S/S32C mutant protein by protein coloured
SDS gel electrophoresis (Fig. 3B), only the protein
with the C16S mutation is detectable by Western
blotting (Fig. 3B). This indicates that changing
Ser32 to Cys completely abolishes antibody binding
to the protein. This con¢rms the C-terminal location
of the antigenic site.
Fig. 3. (A) Antigenic index prediction for g9p, according to
Jameson-Wolf [32]. (B) On the left side is a Western blot of the
C16S and C16S/S32C mutated proteins before (lane 1) and
after overexpression (lane 2). On the right side is a protein col-
oured SDS tricine gel. Lane 1 shows the situation before and
lane 2 after overexpression of the mutant protein C16S/S32C.
Marker protein positions are also indicated (kDa). The arrow
indicates the position of the g9p.
Fig. 2. g9p (1 nmol) added in respectively 4 Wl (b) and 40 Wl
(a) TFE to CF-loaded DOPC at an L/P ratio of 25. (Inset)
g9p (0.8 nmol) added in respectively 50% (v/v) (a) and 20% (v/
v) TFE/water (b) to CF-loaded DOPC at an L/P ratio of 38.
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3.4. Proteinase K digestion experiments
The orientation of g9p in membrane vesicles after
insertion was addressed by proteinase K digestion
experiments. Cleavage of the C-terminal side, which
contains the antigenic site, was followed by the dis-
appearance of intensity on a Western blot. In these
experiments vesicles with inserted g9p were com-
pared with vesicles in which g9p was reconstituted.
The experiment was performed with 200 nm vesicles
consisting of DOPC or DOPG. After incubation,
sucrose density centrifugation followed by Western
blot analysis was performed. Comparing the initial
blot intensities of the inserted and reconstituted sys-
tem before digestion shows that the e⁄ciency for
insertion is low. No inserted protein, which is most
likely aggregated, ended up at the bottom of the tube
after centrifugation (data not shown). Fig. 4 shows
the Western blot of the samples before and after
addition of proteinase K to sucrose gradient puri¢ed
g9p containing DOPC and DOPG vesicles. In com-
paring DOPC and DOPG, it can be seen that after
reconstitution about 69% of the protein in DOPC
and 63% of the protein in DOPG cannot be cleaved
during the time of the experiment. After insertion of
g9p in DOPG and DOPC respectively 12% and 37%
of the initial amount of protein was left after diges-
tion.
4. Discussion
4.1. Interaction with lipids
Monolayer measurements show that g9p has the
ability to penetrate into lipid monolayers of DOPC
and DOPG. Fig. 1 shows that upon addition of pro-
tein to a lipid monolayer the surface pressure in-
creases. Protein molecules that are known to interact
only with the phospholipid head group do not induce
such an increase in surface pressure [27]. Therefore
this increase can be interpreted as the result of pro-
tein insertion in the hydrophobic part of the mono-
layer. We found for monolayers of DOPC as well as
DOPG a limiting surface pressure of about 35 mN/
m. The limiting pressure value is indicative of the
potency of the protein to penetrate into membranes.
The measured limiting pressure for the g9p is in the
range of pressures assumed for biological mem-
branes, for which an ‘equivalence pressure’ of 25^
35 mN/m has been estimated [28]. This indicates
that the ability of the g9p to insert into lipid mono-
layers might as well occur in vivo. The limiting sur-
face pressure is comparable with values found for
other penetrating peptides, such as PhoE and M13
major coat protein signal sequences [29]. With either
lipid, the limiting surface pressure is about 35 mN/m.
Apparently, the insertion is mainly based on hydro-
phobic forces, and less on electrostatic attraction.
Although these experiments show insertion into
monolayers, they do not provide information on
how much and what region of the protein inserts.
Nevertheless, it can be concluded from these mono-
layer experiments that after binding to the membrane
the protein spontaneously insert into the membrane.
Since the monolayer is only half the thickness of
the bilayer and therefore cannot represent the actual
insertion process, we also studied the interaction with
bilayers.
Information on protein penetration into bilayers
was obtained from CF leakage experiments (Fig.
2). Although the mechanism by which leakage is in-
duced is unknown, from Fig. 2 it can be seen that the
initial leakage rate increases with increasing TFE/
protein ratios. Because TFE has a solubilising e¡ect
on the protein, this suggests that smaller protein ag-
gregates and monomers are more e¡ective for leak-
age as compared to large protein aggregates. These
Fig. 4. Western blot of proteinase K digestion experiments of
g9p incorporated in vesicles by reconstitution (Rec), or incorpo-
rated in vesicles by spontaneous insertion (Ins) after sucrose
gradient puri¢cation. The left four lanes represent DOPC, the
right four lanes represent DOPG. In each lipid system the left
two lanes represent inserted (Ins) g9p, and the right two lanes
represent reconstituted (Rec) g9p. The samples without protein-
ase K are marked by 1, the same samples after incubation with
proteinase K are marked by 2. The ¢gures at the bottom indi-
cate the percentage intensity left at the spots after proteinase K
digestion.
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experiments show that g9p is able to interact with
bilayers similar as in the monolayer experiments.
This ¢nding also agrees with the insertion experi-
ments in Fig. 4, which show that the gene 9 protein
is able to integrate with the membrane.
4.2. Orientation after insertion
The ¢nding that the antigenic site is located at the
C-terminal end enabled us to speci¢cally demonstrate
cleavage in the C-terminal region with the help of
antibodies. For the reconstituted g9p the protein is
expected to be randomly oriented, so that 50% of the
C-termini is predicted on the outside of the vesicle.
This fairly well agrees with the 37% reduction of the
spot intensity, observed for DOPG, on the Western
blot. Thus, roughly half of the C-termini is accessible
for proteinase K. For inserted protein, however, a
unique orientation is expected if the N-terminal
side penetrates the membrane, leaving the C-termi-
nus out. In this case, all antigenic sites can be
cleaved, leaving no intensity on blot. If it inserts in
the opposite way, no antigenic site will be cleaved
o¡, resulting in no reduction of the intensity on
blot. The band on the Western blot of inserted g9p
in DOPG disappears almost completely, leaving only
12% of the initial intensity after incubation with pro-
teinase K (Fig. 4). This indicates that almost all C-
terminal ends were accessible and therefore located
outside the vesicle. The band positions of reconsti-
tuted g9p before and after cleavage are the same.
Therefore, the size of the g9p that retains the C-ter-
minus equals the size of the uncleaved protein. This
indicates that the N-terminal region is una¡ected by
proteinase K, since a size reduction in molecular
weight is expected if (part of) the N-terminal would
be clipped o¡. Therefore, it is concluded that the N-
terminus is inserted into the membrane. Comparison
of the reconstituted with the inserted g9p leads to the
conclusion that the protein inserts its N-terminal part
into the DOPG membrane, whereas the C-terminal
region is exposed to the aqueous vesicle exterior. In
the case of DOPC vesicles, the di¡erence between
insertion and reconstitution is less apparent, since
after insertion not all antigenic sites can be cleaved,
leaving a clear band (37%). This e¡ect is probably
due to steric hindrance as a result of vesicle aggre-
gation. This ¢nding is supported by the observation
that addition of only a low molar percentage of
DOPG, thereby introducing vesicle repulsion, re-
sulted in a much better digestion (data not shown).
In conclusion we believe that the g9p inserts with a
speci¢c orientation in phospholipid vesicles, namely
with the N-terminus inserted in the membrane bi-
layer and the C-terminus remaining at the exterior.
Insertion into monolayers occurs at pressures that
are of biological signi¢cance, thereby allowing ex-
trapolating to the in vivo situation in the E. coli
inner membrane. In vivo this would mean that the
C-terminus retains in the cytoplasm. This orientation
agrees with what would be expected based on the
¢nding that the N-terminal formyl group is protected
in the E. coli membrane [14]. Furthermore, the topol-
ogy of the protein is in agreement with the ‘positive
inside rule’ [30,31] and the role of the protein during
phage assembly [10].
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